Mark A. Ware

10.0k total citations · 3 hit papers
118 papers, 5.7k citations indexed

About

Mark A. Ware is a scholar working on Pharmacology, Physiology and Clinical Psychology. According to data from OpenAlex, Mark A. Ware has authored 118 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pharmacology, 30 papers in Physiology and 20 papers in Clinical Psychology. Recurrent topics in Mark A. Ware's work include Cannabis and Cannabinoid Research (63 papers), Pain Mechanisms and Treatments (28 papers) and Musculoskeletal pain and rehabilitation (26 papers). Mark A. Ware is often cited by papers focused on Cannabis and Cannabinoid Research (63 papers), Pain Mechanisms and Treatments (28 papers) and Musculoskeletal pain and rehabilitation (26 papers). Mark A. Ware collaborates with scholars based in Canada, United States and United Kingdom. Mark A. Ware's co-authors include Yoram Shir, Mary Lynch, Stanley H. Shapiro, Ting Wang, Jean‐Philippe Collet, Mary‐Ann Fitzcharles, Laura S. Stone, Jean Ouellet, David A. Seminowicz and Ann Gamsa and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Neuroscience.

In The Last Decade

Mark A. Ware

116 papers receiving 5.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood

2019 548 citations Mark A. Ware et al. profile →
Effective Treatment of Chronic Low Back Pain in Humans Reverses Abnormal Brain Anatomy and Function

2011 465 citations David A. Seminowicz, Timothy H. Wideman et al. Journal of Neuroscience profile →
Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society

2014 369 citations DE Moulin, A. Gordon et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mark A. Ware	4.1k	1.2k	959	774	768	118	5.7k
Milton Cohen	2.8k 0.7×	1.6k 1.4×	1.0k 1.1×	964 1.2×	1.4k 1.8×	81	6.6k
W. Michael Hooten	2.7k 0.7×	1.7k 1.4×	584 0.6×	625 0.8×	1.3k 1.6×	166	6.8k
David A. Fishbain	3.2k 0.8×	1.7k 1.4×	1.0k 1.1×	574 0.7×	1.8k 2.4×	186	6.8k
Patrick H. Finan	1.9k 0.5×	1.1k 0.9×	1.3k 1.4×	341 0.4×	1.2k 1.6×	133	6.2k
Mary Lynch	2.2k 0.5×	1.1k 0.9×	539 0.6×	699 0.9×	641 0.8×	66	4.0k
Samuel A. McLean	1.5k 0.4×	721 0.6×	602 0.6×	584 0.8×	1.4k 1.8×	156	4.1k
Joseph W. Ditre	1.6k 0.4×	1.6k 1.4×	348 0.4×	312 0.4×	690 0.9×	128	4.0k
Vittorio Ventafridda	2.4k 0.6×	1.6k 1.3×	873 0.9×	1.5k 1.9×	1.0k 1.3×	52	6.7k
Dwight E. Moulin	1.8k 0.4×	1.7k 1.4×	628 0.7×	778 1.0×	890 1.2×	112	5.0k
Elon Eisenberg	3.3k 0.8×	3.5k 3.0×	1.0k 1.1×	752 1.0×	699 0.9×	145	7.7k

Countries citing papers authored by Mark A. Ware

Since Specialization

Citations

This map shows the geographic impact of Mark A. Ware's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Ware with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Ware more than expected).

Fields of papers citing papers by Mark A. Ware

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Ware. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Ware. The network helps show where Mark A. Ware may publish in the future.

Co-authorship network of co-authors of Mark A. Ware

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Ware. A scholar is included among the top collaborators of Mark A. Ware based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Ware. Mark A. Ware is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loyd, Andrew L., et al.. (2025). Thiabendazole as a Therapeutic Root Flare Injection for Beech Leaf Disease Management. Arboriculture & Urban Forestry. 51(3). 215–225.

Parisien, Marc, Bogdan Petre, Andrey V. Bortsov, et al.. (2025). Biological markers and psychosocial factors predict chronic pain conditions. Nature Human Behaviour. 9(8). 1710–1725. 3 indexed citations

Kulpa, Justyna, Andrew P. Gigliotti, Wendy W. Dye, et al.. (2024). Biological Response after 14-Day Cannabidiol and Propylene Glycol Inhalation in Sprague–Dawley Rats. Cannabis and Cannabinoid Research. 10(3). 436–444. 1 indexed citations

Moride, Yola, Andrée Néron, Marc O. Martel, et al.. (2023). A Descriptive Analysis of Adverse Event Reports from the Quebec Cannabis Registry. Drug Safety. 47(2). 161–171. 1 indexed citations

Kulpa, Justyna, Wendy W. Dye, Hammad Irshad, et al.. (2022). Pharmacokinetics of Cannabidiol in Sprague-Dawley Rats After Oral and Pulmonary Administration. Cannabis and Cannabinoid Research. 8(2). 360–373. 9 indexed citations

Kulpa, Justyna, Graham M.L. Eglit, Melanie L. Hill, et al.. (2022). Serum Markers of Bone Turnover Following Controlled Administration of Two Medical Cannabis Products in Healthy Adults. Cannabis and Cannabinoid Research. 9(1). 300–309. 5 indexed citations

Ueberall, Michael A., et al.. (2022). Effectiveness and Tolerability of Dronabinol Use in Patients with Chronic Pain: A Retrospective Analysis of 12-Week Open-Label Real-World Data Provided by the German Pain e-Registry. Pain Medicine. 23(8). 1409–1422. 6 indexed citations

Viganò, Antonio, Yola Moride, Marc O. Martel, et al.. (2022). The Quebec Cannabis Registry: Investigating the Safety and Effectiveness of Medical Cannabis. Cannabis and Cannabinoid Research. 8(6). 1106–1116. 8 indexed citations

Peters, Erica N., et al.. (2021). Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec. Cannabis and Cannabinoid Research. 6(6). 564–572. 5 indexed citations

10.

Ware, Mark A., et al.. (2021). Cannabinoid Profiles in Medical Cannabis Users: Effects of Age, Gender, Symptoms, and Duration of Use. Cannabis and Cannabinoid Research. 7(6). 840–851. 13 indexed citations

11.

Lake, Stephanie, Thomas Kerr, Dan Werb, et al.. (2019). Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in Canada. Drug and Alcohol Review. 38(6). 606–621. 27 indexed citations

12.

Bonn‐Miller, Marcel O., Charles V. Pollack, David Casarett, et al.. (2019). Priority Considerations for Medicinal Cannabis-Related Research. Cannabis and Cannabinoid Research. 4(3). 139–157. 23 indexed citations

13.

Abdallah, Sara J., Benjamin M. Smith, Mark A. Ware, et al.. (2018). Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. Annals of the American Thoracic Society. 15(10). 1146–1158. 41 indexed citations

14.

Bostick, Geoff, Steven J. Kamper, Tsjitske M. Haanstra, et al.. (2016). Pain expectations in neuropathic pain: Is it best to be optimistic?. European Journal of Pain. 21(4). 605–613. 6 indexed citations

15.

Moulin, Dwight E., A. J. Clark, Allan Gordon, et al.. (2015). Long-Term Outcome of the Management of Chronic Neuropathic Pain: A Prospective Observational Study. Journal of Pain. 16(9). 852–861. 34 indexed citations

16.

Bostick, Geoff, Cory Toth, Eloise Carr, et al.. (2015). Physical Functioning and Opioid use in Patients with Neuropathic Pain. Pain Medicine. 16(7). 1361–1368. 18 indexed citations

17.

Seminowicz, David A., Timothy H. Wideman, Lina Naso, et al.. (2011). Effective Treatment of Chronic Low Back Pain in Humans Reverses Abnormal Brain Anatomy and Function. Journal of Neuroscience. 31(20). 7540–7550. 465 indexed citations breakdown →

18.

Ware, Mark A., et al.. (2010). The abuse potential of the synthetic cannabinoid nabilone. Addiction. 105(3). 494–503. 49 indexed citations

19.

Shir, Yoram, et al.. (2006). Experience with the Synthetic Cannabinoid Nabilone in Chronic Noncancer Pain. Pain Medicine. 7(1). 25–29. 61 indexed citations

20.

Ware, Mark A.. (1968). The General Medical Journal in Clinical Medicine. New England Journal of Medicine. 278(1). 3–5. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact